Activation of human neutrophils by Esenbeckia leiocarpa: Comparison between the crude hydroalcoholic extract (CHE) and an alkaloid (Alk) fraction

Journal of Inflammation (United Kingdom)

Volumn 9, Issue 1, 2012, Pages

  De Liz, Rafael ^a,b   Horst, Heros ^b   Pizzolatti, Moacir Geraldo ^b   Fröde, Tânia Silvia ^b   Girard, Denis ^a,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Esenbeckia leiocarpa; Inflammation; Neutrophils; Plant extracts

Indexed keywords

ALCOHOL; ALKALOID; ESENBECKIA LEIOCARPA EXTRACT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; PLANT EXTRACT; PROTEIN KINASE SYK; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BARK; CELL ADHESION; CONTROLLED STUDY; DEGRANULATION; DRUG POTENTIATION; ENZYME ACTIVATION; FRACTIONATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NONHUMAN; PHAGOCYTOSIS; RUTACEAE;

EID: 84861429369     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-19     Document Type: Article

References (33)

1. Dolabela MF, Oliveira SG, Nascimento JM, Peres JM, Wagner H, Povoa MM, de Oliveira AB: In vitro antiplasmodial activity of extract and constituents from Esenbeckia febrifuga, a plant traditionally used to treat malaria in the Brazilian Amazon. Phytomedicine 2008, 15: 367-372.
2. Carvalho LH, Brandao MG, Santos-Filho D, Lopes JL, Krettli AU: Antimalarial activity of crude extracts from Brazilian plants studied in vivo in Plasmodium berghei-infected mice and in vitro against Plasmodium falciparum in culture. Braz J Med Biol Res 1991, 24: 1113-1123.
3. Cardoso-Lopes EM, Maier JA, da Silva MR, Regasini LO, Simote SY, Lopes NP, Pirani JR, Bolzani Vda S, Young MC: Alkaloids from stems of Esenbeckia leiocarpa Engl. (Rutaceae) as potential treatment for Alzheimer disease. Molecules 2010, 15: 9205-9213.
4. Aguilar-Guadarrama AB, Rios MY: Geranyl N-dimethylallylanthranilate, a new compound from Esenbeckia yaaxhokob. Planta Med 2004, 70: 85-86.
5. Napolitano HB, Silva M, Ellena J, Rodrigues BD, Almeida AL, Vieira PC, Oliva G, Thiemann OH: Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes. Braz J Med Biol Res 2004, 37: 1847-1852.
6. Liz R, Pereira DF, Horst H, Dalmarco EM, Dalmarco JB, Simionatto EL, Pizzolatti MG, Girard D, Frode TS: Protected effect of Esenbeckia leiocarpa upon the inflammatory response induced by carrageenan in a murine air pouch model. Int Immunopharmacol 2011, 1: 1.
7. Pozzatti P, dos Reis GO, Pereira DF, Heller M, Micke GA, Horst H, Pizzolatti MG, Frode TS: Esenbeckia leiocarpa Engl. inhibits inflammation in a carrageenan-induced murine model of pleurisy. J Pharm Pharmacol 2011, 63: 1091-1102.
8. Nunes FM, Barros-Filho BA, de Oliveira MC, Andrade-Neto M, de Mattos MC, Mafezoli J, Pirani JR: 1H and 13C NMR spectra of 3,8- dimethoxyfuro[3,2-g]coumarin and maculine from Esenbeckia grandiflora Martius (Rutaceae). Magn Reson Chem 2005, 43: 864-866.
9. Nakatsu T, Johns T, Kubo I, Milton K, Sakai M, Chatani K, Saito K, Yamagiwa Y, Kamikawa T: Isolation, structure, and synthesis of novel 4-quinolinone alkaloids from Esenbeckia leiocarpa. J Nat Prod 1990, 53: 1508-1513.
10. Lee YZ, Huang CW, Yang CW, Hsu HY, Kang IJ, Chao YS, Chen IS, Chang HY, Lee SJ: Isolation and Biological Activities of Phenanthroindolizidine and Septicine Alkaloids from the Formosan Tylophora ovata. Planta Med 2011, 4: 4.
11. Ko HC, Wang YH, Liou KT, Chen CM, Chen CH, Wang WY, Chang S, Hou YC, Chen KT, Chen CF, Shen YC: Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. Eur J Pharmacol 2007, 555: 211-217.
12. Wang XH, Jiang SM, Sun QW: Effects of berberine on human rheumatoid arthritis fibroblast-like synoviocytes. Exp Biol Med 2011, 236: 859-866.
13. Kumar V, Sharma A: Neutrophils: Cinderella of innate immune system. Int Immunopharmacol 2010, 10: 1325-1334.
14. Cascao R, Rosario HS, Souto-Carneiro MM, Fonseca JE: Neutrophils in rheumatoid arthritis: More than simple final effectors. Autoimmun Rev 2010, 9: 531-535.
15. Moreno-Navarrete JM, Fernandez-Real JM: Antimicrobial-sensing proteins in obesity and type 2 diabetes: The buffering efficiency hypothesis. Diabetes Care 2011, 34: S335-S341.
16. Mortaz E, Folkerts G, Nijkamp FP, Henricks PA: ATP and the pathogenesis of COPD. Eur J Pharmacol 2010, 638: 1-4.
17. Tintinger GR, Steel HC, Theron AJ, Anderson R: Pharmacological control of neutrophil-mediated inflammation: Strategies targeting calcium handling by activated polymorphonuclear leukocytes. Drug Des Devel Ther 2009, 2: 95-104.
18. Girard D, Paquet ME, Paquin R, Beaulieu AD: Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: Modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood 1996, 88: 3176-3184.
19. Ratthe C, Girard D: Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent mechanism: Importance of the IL-15Ralpha chain. J Leukoc Biol 2004, 76: 162-168.
20. Ennaciri J, Girard D: IL-4R(alpha), a new member that associates with Syk kinase: Implication in IL-4-induced human neutrophil functions. J Immunol 2009, 183: 5261-5269.
21. Simard JC, Simon MM, Tessier PA, Girard D: Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis. J Immunol 2011, 186: 3622-3631.
22. Pelletier M, Girard D: Interleukin-15 increases neutrophil adhesion onto human respiratory epithelial A549 cells and attracts neutrophils in vivo. Clin Exp Immunol 2005, 141: 315-325.
23. Simard JC, Girard D, Tessier PA: Induction of neutrophil degranulation by S100A9 via a MAPK-dependent mechanism. J Leukoc Biol 2010, 87: 905-914.
24. Jog NR, Rane MJ, Lominadze G, Luerman GC, Ward RA, McLeish KR: The actin cytoskeleton regulates exocytosis of all neutrophil granule subsets. Am J Physiol Cell Physiol 2007, 292: C1690-C1700.
25. Binet F, Cavalli H, Moisan E, Girard D: Arsenic trioxide (AT) is a novel human neutrophil pro-apoptotic agent: Effects of catalase on ATinduced apoptosis, degradation of cytoskeletal proteins and de novo protein synthesis. Br J Haematol 2006, 132: 349-358.
26. Binet F, Girard D: Novel human neutrophil agonistic properties of arsenic trioxide: Involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signalregulated kinases-1/2. J Leukoc Biol 2008, .
27. Geering B, Simon HU: Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ 2011, 18: 1457-1469.
28. Akgul C, Moulding DA, Edwards SW: Molecular control of neutrophil apoptosis. FEBS Lett 2001, 487: 318-322.
29. Bouchard A, Ratthe C, Girard D: Interleukin-15 delays human neutrophil apoptosis by intracellular events and not via extracellular factors: Role of Mcl-1 and decreased activity of caspase-3 and caspase-8. J Leukoc Biol 2004, 75: 893-900.
30. Sheppard FR, Kelher MR, Moore EE, McLaughlin NJ, Banerjee A, Silliman CC: Structural organization of the neutrophil NADPH oxidase: Phosphorylation and translocation during priming and activation. J Leukoc Biol 2005, 78: 1025-1042.
31. Hampton MB, Kettle AJ, Winterbourn CC: Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood 1998, 92: 3007-3017.
32. Lopes F, Coelho FM, Costa VV, Vieira EL, Sousa LP, Silva TA, Vieira LQ, Teixeira MM, Pinho V: Resolution of neutrophilic inflammation by H (2) O(2) in antigen-induced arthritis. Arthritis Rheum 2011, 63: 2651-2660.
33. Descamps FJ, Martens E, Opdenakker G: Analysis of gelatinases in complex biological fluids and tissue extracts. Lab Invest 2002, 82: 1607-1608.